Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Organic Chemistry|August 26, 2016
Synthesis of 1,3-Substituted Cyclobutanes by Allenoate-Alkene [2 + 2] CycloadditionMichael L Conner, M Kevin Brown
Journal of the American Chemical Society|March 11, 2015
Catalytic enantioselective allenoate-alkene [2 + 2] cycloadditionsMichael L Conner, Yao Xu, M Kevin Brown
Angewandte Chemie (International Ed. in English)|September 3, 2015
Cyclobutane and cyclobutene synthesis: catalytic enantioselective [2+2] cycloadditionsYao Xu, Michael L Conner, M Kevin Brown
Journal of the American Chemical Society|November 6, 2018
Allenoates in Enantioselective [2+2] Cycloadditions: From a Mechanistic Curiosity to a Stereospecific TransformationJohannes M Wahl, Michael L Conner, M Kevin Brown
Angewandte Chemie (International Ed. in English)|February 27, 2018
Synthesis of (-)-Hebelophyllene E: An Entry to Geminal Dimethyl-Cyclobutanes by [2+2] Cycloaddition of Alkenes and AllenoatesJohannes M Wiest, Michael L Conner, M Kevin Brown
Tetrahedron|October 26, 2020
Thioallenoates in Catalytic Enantioselective [2+2]-Cycloadditions with Unactivated AlkenesMichael L Conner, Johannes M Wiest, M Kevin Brown
ACS Chemical Neuroscience|August 8, 2019
Gracilin A Derivatives Target Early Events in Alzheimer's Disease: in Vitro Effects on Neuroinflammation and Oxidative StressRebeca Alvariño, Eva Alonso, Mikail E Abbasov, et al.
Nature Chemistry|March 24, 2019
Simplified immunosuppressive and neuroprotective agents based on gracilin AMikail E Abbasov, Rebeca Alvariño, Christian M Chaheine, et al.
Journal of Medicinal Chemistry|July 12, 2023
Discovery of IACS-52825, a Potent and Selective DLK Inhibitor for Treatment of Chemotherapy-Induced Peripheral NeuropathyKang Le, Michael J Soth, Jason B Cross, et al.
Pageof 1